"A tenure professor’s calling is in developing a new drug"
By | translator Alice Kang
21.09.16 06:00:30
가나다라
0
Nests at Eulji after 30 years of service at Catholic University Hospital … “want to continue research without worrying about retirement”
Passionate about advancing the treatment of CML, from genome analysis, new drug development, to use of AI in diagnosis
On August 24th, the Hemato-Oncology Department of the Eijeongbu Eulji Medical Center was busy preparing for its new occupant. Professor Dongwook Kim (60), who looked new to his office, was busy discussing matters with various visitors including the hospital employees. Although the center had opened less than 6 months ago, its Hematol-Oncology Department looked more vibrant than ever.
Professor Dongwook Kim, one of the leading authorities in the field of Chronic Myelogenous Leukemia (CML), had joined Eijeongbu Eulji Medical Center of the Eulji University after serving 30 years at the Seoul St.Mary’s Hospital.
During his term at Seoul St.Mary’s Hospital, Professor Kim had made many first-eve
(same@dailypharm.com)
If you want to see the full article, please JOIN US (click)